about
Modulation of T-cell activation by malignant melanoma initiating cellsVEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growthTumor initiation in human malignant melanoma and potential cancer therapiesCancer stem cells (CSCs), cervical CSCs and targeted therapiesCancer stem cells and drug resistance: the potential of nanomedicineCan nanomedicines kill cancer stem cells?A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancerIn vitro models of cancer stem cells and clinical applicationsCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem CellsThe therapeutic promise of the cancer stem cell concept.Cancer stem cells: a systems biology view of their role in prognosis and therapyIKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.CD44 and HCELL: preventing hematogenous metastasis at step 1.Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells.Preliminary analysis of stem cell-like cells in human neuroblastoma.Stacking the DEK: from chromatin topology to cancer stem cells.Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.Cancer stem cells and chemoresistance: The smartest survives the raidColon cancer stem cells: controversies and perspectivesThe role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.A quest for initiating cells of head and neck cancer and their treatment.Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistanceMek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity.Tumor-initiating and -propagating cells: cells that we would like to identify and control.Cancer stem cells and cancer therapy.The role of p63 in cancer, stem cells and cancer stem cells.The role of stem and circulating cells in cancer metastasis.Colorectal cancer stem cells.Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.CREB signalling in neural stem/progenitor cells: recent developments and the implications for brain tumour biology.Cancer stem cells and their potential implications for the treatment of solid tumors.Sarcoma stem cells: do we know what we are looking for?Cancer stem cells, microRNAs, and therapeutic strategies including natural products.Challenges in the development of future treatments for breast cancer stem cells.
P2860
Q24595394-3ECE88B6-564B-4B3D-83AF-353F3F31BC7CQ24606018-F832C369-14C8-4742-8023-E029DF5F02A3Q24634207-94F4F6AC-C2DE-4C18-8AC2-701FC10CA403Q26747144-25507ACE-5648-488F-B94F-C5D709F91191Q26998993-74EE09E2-1C3C-4A80-B39A-3D356E5444BCQ27022017-8BE09D1D-45FA-419F-88C0-EB145EB5BF2EQ27022134-BD35E946-699A-47D1-8A9A-635D94B97163Q28076101-09B6682E-2D82-4549-BEF2-F5AF994C6733Q28081844-B6D05915-EE89-405B-8B2D-D114983BCB6AQ28546641-740A0CDE-207B-4E74-9838-2550F1F464A8Q33559711-97D8C412-72A1-4DF6-99E3-DC24ED424E6AQ33569712-725B67B4-FC42-467C-A076-9B79FEC3F1D8Q33913799-B6E93CC1-DADB-41D4-AFC3-6F88C880DC30Q34233871-AFC27E01-CD76-441A-B0BD-CDBC7B5EF282Q35376738-3C26EF6A-9B65-480C-870D-3EA8DC9DEAC4Q35416653-E39529FA-A12C-41E7-AFC8-51FC850E7617Q35457604-41681F1A-E337-4D73-BAF8-EA5567120C4FQ36604651-97D06F53-0D6C-40A4-8766-D84E7CBD6FD2Q36619069-A950698F-71C6-46BD-B17C-4CCD195F7A97Q36665174-6EB5A20F-D6B0-4997-A884-4EF8DD24AA4EQ36730432-21BF0D4F-255E-4141-B325-82CBB80453B9Q36871965-180D071E-2DDC-48F4-BF96-9913AC109AC1Q37043780-6C68FBDA-CFB3-4D99-AAAE-ED68F866E647Q37334258-E8057614-29B0-439D-8852-9304EC1DE698Q37406832-D9130720-79DB-4407-AF3D-B45DADE31834Q37418121-7DC28628-7B0C-4497-A507-ED7927894E67Q37548863-381127A7-7EBE-47CA-98F4-6B20945D7C8AQ37615286-0190EBFA-6991-4B99-90BE-DEAB88632147Q37667771-3C773654-4421-4D25-98BB-C3416B651ED1Q37774865-53246885-D080-4649-93A3-F4745B84DB42Q37841186-865365E3-9DCB-4630-8F0E-27D59AF68E4BQ37858470-330A8D1D-E521-40F5-8377-B89FFFF46AEDQ37863625-7F35A20B-CCC5-47A5-9D15-6FD9AAD3D6DDQ37974613-0456A1CF-2503-44FB-B2AC-1A02669C5271Q37978771-3129EFD8-8094-47AF-8318-2450A0C42C7FQ37983795-89B7E6DF-8658-45E6-9A4D-64B501DE08D0Q37988791-34CBF45D-C6DA-446D-A75B-B208B94E0697Q38015339-73D9C9D1-2A37-47E5-8C97-05194F8431D0Q38023238-FEF15A3A-C4CD-404C-AD66-8B368F8C75F9Q38239121-D3E2D952-C390-4C04-A279-1CCD839B4059
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification and targeting of cancer stem cells.
@ast
Identification and targeting of cancer stem cells.
@en
type
label
Identification and targeting of cancer stem cells.
@ast
Identification and targeting of cancer stem cells.
@en
prefLabel
Identification and targeting of cancer stem cells.
@ast
Identification and targeting of cancer stem cells.
@en
P2093
P2860
P356
P1433
P1476
Identification and targeting of cancer stem cells.
@en
P2093
Markus H Frank
Natasha Y Frank
Tobias Schatton
P2860
P304
P356
10.1002/BIES.200900058
P407
P577
2009-10-01T00:00:00Z